Citeline, Norstella: drug development merger
Drug development solutions firm Norstella and intelligence provider Citeline have agreed to merge their two organizations. Leadership of the two companies reportedly aim to help life sciences companies bring therapies to patients more rapidly by connecting them with the necessary information and intelligence required from early clinical development to commercialization.
“Accelerating innovation and ensuring that every patient gets the therapy that they need is our North Star,” said Norstella CEO Mike Gallup. “By bringing clinical and commercial intelligence together—along with real-world data—the combined company will be well positioned to deliver on its mission.”